Stock Market News

19 hours There’s a ‘Shadow’ Over Biotech Stocks. Why It Isn‘t All Bad News. Yahoo Finance

There’s a ‘Shadow’ Over Biotech Stocks. Why It Isn‘t All Bad News..

Biotech · Biotech Stocks

15 hours Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell? Zacks

18 hours Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3) Seeking Alpha

1 day Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

2 days Sana Biotech’s islet cell therapy shows promise in diabetes; shares surge 150% postmarket Investing.com

2 days Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4) Seeking Alpha

2 days Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5) Seeking Alpha

2 days Sanofi Down 10% in 3 Months: How Should You Play the Stock? Zacks

3 days Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks

3 days Huge New Year’s Insider Buying From Warren Buffett and Others 24/7 Wall St.

3 days AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell? Zacks

5 days A successful VC predicts what the next 10 years in the venture capital industry will look like Business Insider

6 days Here’s Why Arcutis Stock More Than Doubled in Market Value in One Year Zacks

6 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

6 days Looks Like Tech will lead this year again. Reddit

7 days Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals MarketWatch

7 days MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN Zacks

7 days 5 Large Drug Stocks to Keep An Eye On in the New Year Zacks

7 days Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Zacks

1 week All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy Zacks

1 week Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

1 week This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap. Yahoo Finance

1 week Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

1 week Friday’s Insider Activity: Top Execs Make Moves in Biotech and Retail Investing.com

2 weeks Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks 24/7 Wall St.

2 weeks Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy Seeking Alpha

2 weeks How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

2 weeks 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone Seeking Alpha

2 weeks 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks

2 weeks Should You Invest in the VanEck Biotech ETF (BBH)? Zacks

2 weeks Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

2 weeks 5 Biotech Breakthrough Stocks to Watch in 2025 Zacks

2 weeks Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

2 weeks Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance

3 weeks This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? Yahoo Finance

3 weeks Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

3 weeks 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks

3 weeks KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks

3 weeks Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks

3 weeks Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily

3 weeks Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

3 weeks 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance

3 weeks Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

3 weeks How to play a potential biotech breakout in 2025 with options CNBC

3 weeks 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

3 weeks 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks

3 weeks ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

3 weeks ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

3 weeks Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance

4 weeks KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks

4 weeks RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch